163 related articles for article (PubMed ID: 26019225)
1. CD15 Expression Does Not Identify a Phenotypically or Genetically Distinct Glioblastoma Population.
Kenney-Herbert E; Al-Mayhani T; Piccirillo SG; Fowler J; Spiteri I; Jones P; Watts C
Stem Cells Transl Med; 2015 Jul; 4(7):822-31. PubMed ID: 26019225
[TBL] [Abstract][Full Text] [Related]
2. The identification of human pituitary adenoma-initiating cells.
Manoranjan B; Mahendram S; Almenawer SA; Venugopal C; McFarlane N; Hallett R; Vijayakumar T; Algird A; Murty NK; Sommer DD; Provias JP; Reddy K; Singh SK
Acta Neuropathol Commun; 2016 Nov; 4(1):125. PubMed ID: 27894339
[TBL] [Abstract][Full Text] [Related]
3. The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas.
Kim KJ; Lee KH; Kim HS; Moon KS; Jung TY; Jung S; Lee MC
Neuropathology; 2011 Oct; 31(5):494-502. PubMed ID: 21269333
[TBL] [Abstract][Full Text] [Related]
4. Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15.
Mao XG; Zhang X; Xue XY; Guo G; Wang P; Zhang W; Fei Z; Zhen HN; You SW; Yang H
Transl Oncol; 2009 Dec; 2(4):247-57. PubMed ID: 19956386
[TBL] [Abstract][Full Text] [Related]
5. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
6. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid induces mouse bone marrow-derived CD15⁺, Oct4⁺ and CXCR4⁺ stem cells into male germ-like cells in a two-dimensional cell culture system.
Kashani IR; Zarnani AH; Soleimani M; Abdolvahabi MA; Nayernia K; Shirazi R
Cell Biol Int; 2014 Jun; 38(6):782-9. PubMed ID: 24677291
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cancer stem-like cells in chordoma.
Aydemir E; Bayrak OF; Sahin F; Atalay B; Kose GT; Ozen M; Sevli S; Dalan AB; Yalvac ME; Dogruluk T; Türe U
J Neurosurg; 2012 Apr; 116(4):810-20. PubMed ID: 22283189
[TBL] [Abstract][Full Text] [Related]
9. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
[TBL] [Abstract][Full Text] [Related]
10. CDC20 maintains tumor initiating cells.
Xie Q; Wu Q; Mack SC; Yang K; Kim L; Hubert CG; Flavahan WA; Chu C; Bao S; Rich JN
Oncotarget; 2015 May; 6(15):13241-54. PubMed ID: 25938542
[TBL] [Abstract][Full Text] [Related]
11. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
[TBL] [Abstract][Full Text] [Related]
12. The evidence of glioblastoma heterogeneity.
Soeda A; Hara A; Kunisada T; Yoshimura S; Iwama T; Park DM
Sci Rep; 2015 Jan; 5():7979. PubMed ID: 25623281
[TBL] [Abstract][Full Text] [Related]
13. Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations.
Grasso C; Anaka M; Hofmann O; Sompallae R; Broadley K; Hide W; Berridge MV; Cebon J; Behren A; McConnell MJ
BMC Cancer; 2016 Sep; 16(1):726. PubMed ID: 27613604
[TBL] [Abstract][Full Text] [Related]
14. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.
Singh AR; Joshi S; Zulcic M; Alcaraz M; Garlich JR; Morales GA; Cho YJ; Bao L; Levy ML; Newbury R; Malicki D; Messer K; Crawford J; Durden DL
PLoS One; 2016; 11(3):e0150836. PubMed ID: 26938241
[TBL] [Abstract][Full Text] [Related]
15. Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?
Lemke D; Weiler M; Blaes J; Wiestler B; Jestaedt L; Klein AC; Löw S; Eisele G; Radlwimmer B; Capper D; Schmieder K; Mittelbronn M; Combs SE; Bendszus M; Weller M; Platten M; Wick W
J Neurochem; 2014 Oct; 131(2):251-64. PubMed ID: 24976529
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of cancer testis antigens modulates neural stem cell marker expression in glioblastoma tumor stem cells.
Low J; Dowless M; Shiyanova T; Rowlinson S; Ricci-Vitiani L; de Maria R; Pallini R; Stancato L
J Biomol Screen; 2010 Aug; 15(7):830-9. PubMed ID: 20639497
[TBL] [Abstract][Full Text] [Related]
17. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and functional heterogeneity of GFAP-expressing cells in vitro: differential expression of LeX/CD15 by GFAP-expressing multipotent neural stem cells and non-neurogenic astrocytes.
Imura T; Nakano I; Kornblum HI; Sofroniew MV
Glia; 2006 Feb; 53(3):277-93. PubMed ID: 16267834
[TBL] [Abstract][Full Text] [Related]
19. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1.
Fukaya R; Ohta S; Yamaguchi M; Fujii H; Kawakami Y; Kawase T; Toda M
Cancer Lett; 2010 May; 291(2):150-7. PubMed ID: 19913993
[TBL] [Abstract][Full Text] [Related]
20. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
